安杰利尼以1.2亿美元收购Quiver Bioscience,瞄准AI生物技术领域。
Angelini nocks an AI arrow with $120M Quiver Bioscience deal
生物技术与制药领域的最新动态
Angelini nocks an AI arrow with $120M Quiver Bioscience deal
AbbVie budgets $380M for obesity and neuroscience API facilities in Chicago
2025 report: Spain’s Catalonia region a European life sciences leader
Unorthodox ‘universal vaccine’ offers broad protection in mice
A little-known flu virus is sickening cattle around the world. Are humans next?
Scientists decry Trump’s rush to loosen radiation exposure standards
Scimitar-crested Spinosaurus species from the Sahara caps stepwise spinosaurid radiation | Science
Implanted flexible electronics reveal principles of human islet cell electrical maturation | Science
CLK and/or DYRK inhibitors disclosed in Tarapeutics Science patent
Omnigeniq’s journey from space science to drug design
Thermo Fisher Scientific expands real-world data interoperability and linkage through partnership with Datavant - SelectScience
More Than Beer and Cheese: Why Wisconsin Has Always Been Good Ground for Science
Integra LifeSciences cuts roles as 65 staffers impacted from Princeton, N.J., site
Ovid takes another big swing in neuroscience under a new CEO
Can science build a better working dog?
Politics and war complicate global effort to study changes to Earth’s poles
Structural ontogeny of protein-protein interactions | Science
Detecting supramolecular organic nanoparticles during heat wave | Science
Mechanisms linking cytoplasmic decay of translation-defective mRNA to transcriptional adaptation | Science
Precision Biosciences’ PBGENE-DMD cleared to enter clinic